Cite
HARVARD Citation
Riedl, M. et al. (2017). Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial. Lancet. 390 (10102), pp. 1595-1602. [Online].